cannabis bud over european union flag

Catch up on some of the biggest news in the cannabis investment world from the past week.

A US-based multi-state operator (MSO) announced it has set aside a new company division that will pursue the European cannabis market.

Also this week, a cannabis research firm revealed that cannabis now holds a position as one of the most highly valued crops in the US.

Keep reading to find out more cannabis highlights from the past five days.


Curaleaf subsidiary betting heavily on European growth

Curaleaf Holdings (CSE:CURA) announced that its subsidiary EMMAC Life Sciences Group will now operate as Curaleaf International and will target opportunities in the burgeoning European cannabis market.

"The landscape in Europe is changing and we can see similar clear patterns to the progress in North America for adult use cannabis," Antonio Costanzo, CEO of Curaleaf International, said in a statement to shareholders.

The company said it expects the value of the entire European cannabis market to sit at 3.2 billion euros by 2025.

Boris Jordan, founder and executive chairman of Curaleaf, has been a heavy proponent of the European opportunity and its role in the growth of MSOs beyond the US. He recently joined the board of the Bloomwell Group, a German cannabis company.

Earlier this year, Jordan tipped his hand about his level of interest in the European opportunity.

"The Europeans are taking a more careful approach to this and a far more pharmaceutical medical approach than the United States did," Jordan said during an online cannabis event.

Cannabis earns spot among highest-valued crops in US

According to a new dataset from market researcher Leafly Holdings (NASDAQ:MCMJ), cannabis is now the fifth most valuable crop in the US market, beating cotton, rice and peanuts.

Cannabis is worth US$6.2 billion in annual wholesale value, the report indicates. Corn stands alone as the most valuable crop, represented by a US$61 billion value line.

David Downs, lead author of the report and Leafly's California bureau chief, described the return from cannabis as "mind-boggling," and highlighted the need for cannabis federal reform.

"This plant is helping generate wealth, employment, and community investment around the country, and our legislators need to recognize the opportunity cannabis presents for Americans — today," Downs said.

The study was completed in partnership with Whitney Economics.

Cannabis company news

  • Canopy Growth (NASDAQ:CGC,TSX:WEED) released the financial report for its fiscal Q2 2022 period. The company reported $131.4 million in revenue, a decrease from last year, while also posting a loss of $162.6 million for its EBITDA. "In new industries where the potential is immense, progress is rarely a straight line," CEO David Klein said.
  • Avicanna (TSX:AVCN,OTCQX:AVCNF) confirmed the receipt of Good Agricultural and Collection Practices (GACP) certification in Colombia for its subsidiary Santa Marta Golden Hemp. "Coupled with the new regulatory framework in Colombia which would authorize the export of flower; we will now deliver GACP and organic certified flower from our greenhouse and outdoor modalities to the global market," Lucas Nosiglia, president of Avicanna LATAM, said.
  • Columbia Care (NEO:CCHW,CSE:CCHW,OTCQX:CCHWF) completed an acquisition worth US$42 million to obtain vertically integrated Colorado-based cannabis company Medicine Man.
  • Organigram Holdings (NASDAQ:OGI,TSX:OGI) issued a corporate update to shareholders in which it outlines recent events for its product presence in Canada. "Our industry-leading market share growth really highlights the continued momentum that Organigram is experiencing in the market," Beena Goldenberg, CEO of Organigram, said.

Don't forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Featured
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofCronos Group Inc. for violations of the securities lawsThe investigation focuses on whether the Company issued false andor misleading statements andor failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofCronos Group Inc. ("Cronos" or "the Company") (NASDAQ:CRON) for violations of the securities laws

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the Company would "be required to restate its previously issued unaudited interim financial statements for the three and six months ended June 30, 2021" and that "the Company's financial statements for this period should therefore no longer be relied upon." Based on this news, shares of Cronos fell by nearly 16%.

read more Show less
The company's first ESG report outlines efforts to operate with integrity and support long-term sustainability Trulieve Cannabis Corp. the largest multi-state operator in the United States today announced the publication of its first Environmental, Social, and Governance Report . The Report contains standard disclosures from the Global Reporting Initiative Sustainability Reporting Standards, The Sustainability ...

The company's first ESG report outlines efforts to operate with integrity and support
long-term sustainability

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), the largest multi-state operator (MSO) in the United States today announced the publication of its first Environmental, Social, and Governance (ESG) Report (the "Report"). The Report contains standard disclosures from the Global Reporting Initiative (GRI) Sustainability Reporting Standards, The Sustainability Accounting Standards Board (SASB) as well as the United Nations Sustainable Development Goals. The Report highlights ESG achievements to date and serves as a foundation for demonstrating how the Company's ESG approach, strategies and commitments are embedded within its core business.

read more Show less
Pomerantz LLP is investigating claims on behalf of investors of Cronos Group Inc. . Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Cronos and certain of its officers andor directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On ...

Pomerantz LLP is investigating claims on behalf of investors of Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ: CRON). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Cronos and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

read more Show less

MARKETS

Markets
TSX21149.00+23.10
TSXV954.26+10.21
DOW35135.94+236.60
S&P 5004655.27+60.65
NASD15782.83+291.18
ASX7239.80-39.50

COMMODITIES

Commodities
Gold1788.98+2.35
Silver22.93+0.01
Copper4.33-0.01
Palladium1804.53+15.61
Platinum955.43-10.56
Oil70.57+0.62
Heating Oil2.16+0.01
Natural Gas4.84-0.01